Vericel (VCEL) Times Interest Earned (2010 - 2026)
Vericel (VCEL) reported Times Interest Earned of -$12.9 for Q1 2026, up 36.96% on a YoY basis from -$9.42 in Q1 2025, and down 109.32% sequentially from $138.36 in Q4 2025.
Vericel (VCEL) Times Interest Earned (2010 - 2026) Analysis & Trends
Vericel (VCEL) has 17 years of Times Interest Earned data on file, last reported at -$12.9 in Q1 2026.
- For the quarter ending Q1 2026, Times Interest Earned rose 36.96% year-over-year to -$12.9; the trailing twelve-month figure through Mar 2026 stood at $25.24 (up 661.48% YoY), and the FY2025 full-year result was $0.27, up 714.92% from the prior year.
- Times Interest Earned declined to -$12.9 in Q1 2026, from $138.36 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $138.36 in Q4 2025 to a low of -$454.1 in Q2 2022.
- A 5-year average of -$41.64 and a median of -$3.94 in 2024 frame the typical range for Times Interest Earned.
- Peak annual rise in Times Interest Earned reached 612.55% in 2024, while the deepest fall reached 12203.69% in 2024.
- Tracing VCEL's Times Interest Earned over 5 years: stood at $6.36 in 2022, then jumped by 164.85% to $16.84 in 2023, then jumped by 612.55% to $119.99 in 2024, then climbed by 15.31% to $138.36 in 2025, then sank by 109.32% to -$12.9 in 2026.
- Business Quant data shows VCEL's Times Interest Earned at -$12.9 in Q1 2026, $138.36 in Q4 2025, and $5.52 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn | -12.90 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.90 |
| Dec 31, 2025 | 138.36 |
| Sep 30, 2025 | 5.52 |
| Jun 30, 2025 | -3.25 |
| Mar 31, 2025 | -20.47 |
| Dec 31, 2024 | 119.99 |
| Sep 30, 2024 | -3.94 |
| Jun 30, 2024 | -9.65 |
| Mar 31, 2024 | -8.74 |
| Dec 31, 2023 | 16.84 |
| Sep 30, 2023 | -0.03 |
| Jun 30, 2023 | -0.12 |
| Mar 31, 2023 | -13.08 |
| Dec 31, 2022 | 6.36 |
| Sep 30, 2022 | -64.65 |
| Jun 30, 2022 | -454.10 |
| Mar 31, 2022 | -404.06 |
| Dec 31, 2021 | 4,141.00 |
| Sep 30, 2021 | -4,961.00 |
| Jun 30, 2021 | -3,729.00 |